Jenny Rooke
Managing Director at Genoa Ventures
San Francisco, California
Overview
Work Experience
Managing Director
2012 - Current
Genoa Ventures (formerly 5 Prime Ventures) invests in early-stage companies innovating at the intersection of biology and technology, with a focus on opportunities in research tools, molecular diagnostics, synthetic biology, ag biotech, and industrial biology.
Genoa Ventures is a venture capital firm that invests in early-stage life sciences technology companies.
Investor, Board Observer
2023
Fellow provides peer-reviewed, clinical semen analysis solutions that patients can conveniently perform at home.
Investor, Director
2022
Brightspec provides analytical chemistry solutions using FT-MRR spectroscopy, a new commercial technique for direct.
Raised $21,095,928.00 from Genoa Ventures, Felton Group LLC, Arboretum Ventures, UVA Licensing & Ventures Group and Medvest Capital.
Investor, Board Observer
2022
General Inception is an institutional co-founder for science-based companies.
Investor
2021
Redux Bio is a product development company.
Investor, Director
2021
Stemson Therapeutics is a pre-clinical stage cell therapy company.
Raised $22,500,000.00 from Genoa Ventures, AbbVie and DCVC Bio.
Investor, Director
2021
Investor, Director
2021
Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology and biochemistry for chronic disease.
Raised $16,000,000.00 from Genoa Ventures, Yu Galaxy and Manta Ray Ventures.
Investor
2020
Member Board of Trustees
2019